Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

1(33%)

Results Posted

100%(1 trials)

Phase Distribution

Ph not_applicable

67%

Ph phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(1)

Detailed Status

Completed1

Enrolling by invitation1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (33.3%)

N/A2 (66.7%)

Trials by Status

completed133%

enrolling_by_invitation133%

recruiting133%

Recent Activity

1 active trials

Showing 3 of 3

recruitingphase_1

Clinical Application Comparison of Two Femtosecond Laser Systems

NCT06754358

enrolling_by_invitationnot_applicable

Comparative Study on Changes in Anterior Chamber Cytokines, Oxidative Stress, and Pupil Size After LenSx and Z8 Femtosecond Lasers

NCT06649799

completednot_applicable

Clinical Evaluation of FLACS With Combination of LenSx® and Centurion®

NCT03479944

Clinical Trials (3)

Showing 3 of 3 trials

NCT06754358Phase 1

Clinical Application Comparison of Two Femtosecond Laser Systems

Recruiting

NCT06649799Not Applicable

Comparative Study on Changes in Anterior Chamber Cytokines, Oxidative Stress, and Pupil Size After LenSx and Z8 Femtosecond Lasers

Enrolling By Invitation

NCT03479944Not Applicable

Clinical Evaluation of FLACS With Combination of LenSx® and Centurion®

Completed

All 3 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 3